Physician profile
Patrick J Stuart
NPI 1104811330
$1,475.73
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $324 · 2021: $278 · 2022: $53.61.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.79 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $261.27 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $161.78 | 2019-2021 | |
| Glaxosmithkline, LLC. | $148.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $127.24 | 2019-2021 | |
| Amgen INC. | $124.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.89 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $67.30 | 2021 | |
| Allergan, INC. | $56.53 | 2020 | |
| Astellas Pharma US INC | $35.52 | 2019 | |
| Eisai INC. | $22.36 | 2021 | |
| Abbvie INC. | $17.68 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.27 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.12 | 2020 | |
| Bioventus LLC | $14.67 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.53 | 2019 | |
| Amarin Pharma, INC. | $13.41 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.